Conjunctisan A

A product specifically designed to treat agerelated eye disorders such as cataracts, Conjunctisan A contains natural lysates, which purport to improve eye conditions by stimulating the natural healing and repair processes. Regular, longer use of conjunctisan A may improve eyesight in cataract suffers, as well as myopia.

Conjunctisan A’s anti-aging potential benefits include treatment and prevention of cataracts, improvement of eye irritation due to environmental factors, and general improvement of aging eye deterioration due to macular degeneration, opacity of the lens, retina changes and degenerative eye complaints. One study found that Conjunctisan A improved the vision of 65% of cataract sufferers. Conjunctisan A is considered to be a homeopathic medicine. When used continuously for 4 to 6 weeks some users may benefit from improved vision; after that period, it is important to continue a maintenance program in order for the condition not to regress.

No known side effects or contraindications have been reported by the manufacturer.

This product contains a plethora of bovine origin macromolecular organ factors from corresponding eye sections. Each liquid capsule contains; 0.2ng bulb.oc. fet., 0.05ng lenx, 0.lng fet. Vessels, 0.l5ng placenta fet., 0.05pg retina, 0.05pg optic nerve, 0.lpg choriod, 0.lpg hyaloivd body, 0.05pg cerebral cortx, 0.05pg diencephalon as well as the pharmaceutical substances 0.074ug deslanoside C, 5ug aesulin and 5ug sodium dodecyl sulfate, 4% glycerol and 0.5ml saline (0.7%).

Distribution: VitOrgan of Germany distributes Conjunctisan A in 0.5 ml liquid droppers.